Clinical Report: A Rare Case of T-Cell Acute Lymphoblastic Leukemia in Down Syndrome
Overview
This report describes a rare case of T-cell acute lymphoblastic leukemia (T-ALL) in a 7-year-old boy with Down syndrome (DS), highlighting the genetic characteristics and treatment challenges. The patient exhibited a favorable response to chemotherapy despite severe complications during treatment.
Background
Children with Down syndrome have a significantly higher incidence of acute lymphoblastic leukemia (ALL), predominantly of B-cell precursor origin. The occurrence of T-cell ALL in this population is exceptionally rare and poorly characterized, with limited treatment guidelines available. Understanding the genetic and clinical aspects of T-ALL in DS is crucial for informing treatment decisions and improving patient outcomes.
Data Highlights
No numerical data available.
Key Findings
The patient was diagnosed with T-ALL, presenting with leukocytosis, mediastinal mass, and CNS involvement.
Genetic studies revealed a complex karyotype with translocation t(1;14)(p32;q11) and deletion of chromosome 9p.
Pathogenic variants in NOTCH1 and FBXW7 were identified through next-generation sequencing.
The patient achieved minimal residual disease negativity after an anthracycline-free induction chemotherapy.
This case represents the first detailed genetic characterization of T-ALL in a child with Down syndrome.
Clinical Implications
Clinicians should be aware of the unique genetic alterations associated with T-ALL in patients with Down syndrome, which differ from those seen in B-cell precursor ALL. Treatment protocols may need to be adapted to account for the increased susceptibility to complications in this fragile population.
Conclusion
This case underscores the rarity of T-ALL in Down syndrome and highlights the importance of genetic characterization in guiding treatment. Enhanced understanding of this condition may improve clinical outcomes for affected patients.
